Literature DB >> 9160326

Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis.

P Dobner1, G Bretzel, S Rüsch-Gerdes, K Feldmann, M Rifai, T Löscher, H Rinder.   

Abstract

Specific mutations associated with resistance to streptomycin (SM) in Mycobacterium tuberculosis suggest themselves for its rapid prediction. However, as with any diagnostic test, their predictive values are dependent on their prevalences. In this report, SM resistance associated mutations in the rrs and rpsL genes of 25 SM resistant isolates from Germany and 25 SM resistant isolates from Sierra Leone were characterized and compared. Mutations in the rrs gene were infrequent in isolates from both localities (20% and 12%, respectively) and thus of limited predictive values. In contrast, rpsL mutations were found in 48% of the German isolates but only in 24% of the isolates from Sierra Leone. It is concluded that the predictive values of mutations in this gene may vary significantly with the origin of the samples under investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160326     DOI: 10.1006/mcpr.1996.0086

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  8 in total

1.  Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community.

Authors:  A Van Rie ; R Warren; I Mshanga; A M Jordaan; G D van der Spuy ; M Richardson; J Simpson; R P Gie; D A Enarson; N Beyers; P D van Helden ; T C Victor
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia.

Authors:  Beatriz E Ferro; Pamela K García; Luisa Maria Nieto; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.

Authors:  Annika Krüüner; Pontus Jureen; Klavdia Levina; Solomon Ghebremichael; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

4.  High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.

Authors:  Levan Jugheli; Nino Bzekalava; Pim de Rijk; Krista Fissette; Françoise Portaels; Leen Rigouts
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

5.  Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting.

Authors:  Silke Feuerriegel; Barbara Oberhauser; Abu Garawani George; Foday Dafae; Elvira Richter; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  BMC Microbiol       Date:  2012-05-30       Impact factor: 3.605

6.  Fluoromycobacteriophages Can Detect Viable Mycobacterium tuberculosis and Determine Phenotypic Rifampicin Resistance in 3-5 Days From Sputum Collection.

Authors:  Liliana Rondón; Estefanía Urdániz; Cecilia Latini; Florencia Payaslian; Mario Matteo; Ezequiel J Sosa; Darío F Do Porto; Adrian G Turjanski; Sergio Nemirovsky; Graham F Hatfull; Susana Poggi; Mariana Piuri
Journal:  Front Microbiol       Date:  2018-07-05       Impact factor: 5.640

7.  Combined species identification, genotyping, and drug resistance detection of Mycobacterium tuberculosis cultures by MLPA on a bead-based array.

Authors:  Indra Bergval; Sarah Sengstake; Nadia Brankova; Viktoria Levterova; Edgar Abadía; Nino Tadumaze; Nino Bablishvili; Maka Akhalaia; Kiki Tuin; Anja Schuitema; Stefan Panaiotov; Elizabeta Bachiyska; Todor Kantardjiev; Rina de Zwaan; Anita Schürch; Dick van Soolingen; Anja van 't Hoog; Frank Cobelens; Rusudan Aspindzelashvili; Christophe Sola; Paul Klatser; Richard Anthony
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

8.  Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland.

Authors:  Tomasz Jagielski; Helena Ignatowska; Zofia Bakuła; Łukasz Dziewit; Agnieszka Napiórkowska; Ewa Augustynowicz-Kopeć; Zofia Zwolska; Jacek Bielecki
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.